Gentiva gains on upbeat Q2 outlook

Gentiva Health Sciences’ shares gain after the company, which has rejected Kindred Healthcare’s buyout bids, provided a second-quarter earnings outlook that was above analyst expectations.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.